Currently, there are 302.46M common shares owned by the public and among those 301.89M shares have been available to trade.
The company’s stock has a 5-day price change of 0.26% and -19.48% over the past three months. ALLY shares are trading 0.14% year to date (YTD), with the 12-month market performance up to 42.27% higher. It has a 12-month low price of $22.54 and touched a high of $45.46 over the same period. ALLY has an average intraday trading volume of 3.62 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.29%, -7.57%, and -8.78% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Ally Financial Inc (NYSE: ALLY) shares accounts for 89.90% of the company’s 302.46M shares outstanding.
It has a market capitalization of $10.65B and a beta (3y monthly) value of 1.39. The stock’s trailing 12-month PE ratio is 15.10, while the earnings-per-share (ttm) stands at $2.32. The company has a PEG of 0.51 and the debt-to-equity ratio at 1.39. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.43% over the week and 2.50% over the month.
Earnings per share for the fiscal year are expected to decrease by -12.55%, and 72.18% over the next financial year. EPS should grow at an annualized rate of 29.57% over the next five years, compared to 0.20% over the past 5-year period.
Looking at the support for the ALLY, a number of firms have released research notes about the stock. JP Morgan stated their Overweight rating for the stock in a research note on October 07, 2024, with the firm’s price target at $46-$40. JP Morgan was of a view on July 08, 2024 that the stock is Neutral, while Citigroup gave the stock Buy rating on June 24, 2024, issuing a price target of $50. BTIG Research on their part issued Buy rating on June 07, 2024.
